INO Therapeutics
Biotechnology Research • • 1-10 Employees
Company overview
| Headquarters | XX |
| NAICS | 541714 |
| Employees | 1-10 |
Key Contact at INO Therapeutics
Kate Lenox
Director
About INO Therapeutics
INOMAX® treats hypoxic respiratory failure (HRF) in term and near-term infants.
$
INO Therapeutics revenue & valuation
| Annual revenue | $85,555 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $273,776 |
| Total funding | No funding |
Employees by Management Level
Total employees: 1-10
Seniority
Employees
Director
Funding Data
INO Therapeutics has never raised funding before.
Poland
United Kingdom
CanadaFrequently asked questions
INO Therapeutics is located in XX.
INO Therapeutics has approximately 1-10 employees. The company continues to grow its workforce to support its business operations and expansion.
4.8
40,000 users
